A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback